Unibest

Pharmaceutical intermediates

Ertugliflozin Intermediates

2 pharmaceutical intermediates for Ertugliflozin. Indication: Type 2 diabetes mellitus.

Submit a ProjectAll intermediates

About Ertugliflozin

Originator
Pfizer Inc
Indication
Type 2 diabetes mellitus
Approved Date
12/19/2017
DS/DP
07/13/2030

Available intermediates

2 intermediates currently listed for Ertugliflozin. Request specifications, documentation or a quotation for any item below.

Ertugliflozin intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
2-((benzyloxy)(4-ethoxyphenyl)methyl)-4-bromo-1-chlorobenzene1298086-15-3//
(2R, 3S.4S)-2, 3, 4-tris(benzyloxy)-4-((R)-4-((benzyloxy)meth yl)-2, 2-dimeth yl-1, 3- dioxolan-4-yl)-1-(4-methylDiDerazin-1-yl)butan-1-one1431329-07-5//

Other programs under E

Edoxaban tosylate monohydrateElacestrantElagolix SodiumEldecalcitolElinzanetantElobixibatEltrombopagEltrombopag Olamine

Building toward Ertugliflozin?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →